Related Experiment Video
Updated: Jul 15, 2026
Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Published on: November 6, 2017
Secretory PLA2-IIA and ROS generation in peripheral mitochondria are critical for neuronal death
Gro H Mathisen1, Inger H Thorkildsen, Ragnhild E Paulsen
1Department of Pharmaceutical Biosciences, University of Oslo, Blindern, N-0316 Oslo, Norway.
Abstract:
In this study the role of mitochondrial secretory PLA2-IIA in glutamate-induced cell death in cultured cerebellar granule neurons has been investigated. Inhibition of secretory PLA2-IIA blocked glutamate-induced cell death. Since PLA2 may generate reactive oxygen species (ROS), we have investigated ROS production, detected as dihydrorhodamine 123 oxidation and nitrotyrosine modifications of proteins, following glutamate treatment in the absence or presence of an inhibitor of secretory PLA2-IIA. There was an increased generation of ROS in both glutamate- and buffer-treated neurons compared to untreated neurons. Scavenging with dihydrorhodamine 123 reduced glutamate-induced death (60%), showing that ROS detected in glutamate-treated neurons were associated with cell death. However, ROS detected in buffer-treated neurons were not associated with toxicity. Glutamate treatment led to ROS production predominantly in peripheral mitochondria, whereas buffer treatment led to ROS production in somal mitochondria. Inhibition of secretory PLA2-IIA (i) reduced the generation of ROS after glutamate treatment, (ii) reduced the ROS production in peripheral mitochondria in glutamate-treated neurons, consistent with the fact that calcium entry through glutamate (NMDA) receptors has a privileged access to peripheral mitochondria, and (iii) did not reduce the generation of ROS after buffer treatment. In conclusion, activation of NMDA receptors induces ROS, which is critical for neuronal death, due to secretory PLA2-IIA associated with peripheral mitochondria.
Insights
Secretory phospholipase A2-IIA (PLA2-IIA) drives glutamate-induced neuronal death by generating reactive oxygen species (ROS) in peripheral mitochondria. Inhibiting PLA2-IIA prevents this ROS production and subsequent cell death.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Glutamate excitotoxicity is a major cause of neuronal death.
- Mitochondria play a critical role in cellular stress responses and cell death pathways.
- Secretory phospholipase A2-IIA (PLA2-IIA) is implicated in inflammatory and cell death processes.
Purpose of the Study:
- To investigate the role of mitochondrial secretory PLA2-IIA in glutamate-induced cell death in cerebellar granule neurons.
- To determine if PLA2-IIA activity and reactive oxygen species (ROS) generation are linked to glutamate toxicity.
- To identify the mitochondrial localization of ROS production.
Main Methods:
- Cultured cerebellar granule neurons were treated with glutamate or buffer.
- Inhibition of secretory PLA2-IIA was achieved using specific inhibitors.
- Reactive oxygen species (ROS) production was measured using dihydrorhodamine 123 oxidation and nitrotyrosine modifications.
- Neuronal death was quantified following treatment and ROS scavenging.
Main Results:
- Inhibition of secretory PLA2-IIA blocked glutamate-induced neuronal death.
- Glutamate treatment increased ROS generation, particularly in peripheral mitochondria, which was linked to cell death.
- Scavenging ROS significantly reduced glutamate-induced neuronal death.
- PLA2-IIA inhibition reduced glutamate-induced ROS generation in peripheral mitochondria.
- Buffer treatment also increased ROS but not associated with toxicity and localized to somal mitochondria.
Conclusions:
- Activation of NMDA receptors by glutamate induces ROS production critical for neuronal death.
- Secretory PLA2-IIA associated with peripheral mitochondria is a key mediator of this glutamate-induced ROS production and subsequent cell death.
- Targeting PLA2-IIA may offer a therapeutic strategy for conditions involving glutamate excitotoxicity.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:24Parkinson Disease ll: Pathophysiology